Screener
Veracyte VCYT Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $6,908 | $4,593 |
| Accrued liabilities | 43,129 | 48,801 |
| Current portion of deferred revenue | 749 | 1,160 |
| Current portion of acquisition-related contingent consideration | 982 | 1,332 |
| Current portion of operating lease liabilities | 4,347 | 4,051 |
| Total current liabilities | 56,115 | 59,937 |
| Deferred tax liabilities | 636 | 646 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's deferred revenue?
- Veracyte (VCYT) reported deferred revenue of $749K in Q1 2026.
- How has Veracyte's deferred revenue changed year-over-year?
- Veracyte's deferred revenue decreased by 56.3% year-over-year, from $1.71M to $749K.
- What is the long-term trend for Veracyte's deferred revenue?
- Over 5 years (2020 to 2025), Veracyte's deferred revenue has grown at a 25.6% compound annual growth rate (CAGR), from $371K to $1.16M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Veracyte's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude